Perspective Therapeutics, Inc. — Director's Dealing 2024

Jun 24, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2024-06-20

Reporting Person: Williamson Robert F III (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-20	Stock option (right to buy)	$10.65	A	23000	Acquired	2034-06-20	Common Stock (23000)	Direct

Footnotes

F1: This option shall fully vest on the first anniversary after the Grant Date (06/20/2024), subject to a continued service relationship.